Collectively, this integrated transcriptomic and regulatory analysis reveals specific molecular candidates that link disruption of YAP/TAZ–TEAD signaling in VSMCs to the pathogenesis of atherosclerosis. The gene discussed is YAP1; the disease is atherosclerosis.